Investigation of cell free BIRC5 mRNA as a serum diagnostic and prognostic biomarker for colorectal cancer

Journal of Surgical Oncology

Volumn 109, Issue 6, 2014, Pages 574-579

  Wang, Haiyan ^a   Zhang, Xin ^a   Wang, Lili ^a   Zheng, Guixi ^a   Du, Lutao ^a   Yang, Yongmei ^a   Dong, Zhaogang ^a   Liu, Yimin ^a   Qu, Ailin ^a   Wang, Chuanxin ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

cell free BIRC5 mRNA; colorectal cancer; diagnosis; prognosis

Indexed keywords

BIOLOGICAL MARKER; CELL FREE MESSENGER RNA; MESSENGER RNA; SURVIVIN; UNCLASSIFIED DRUG;

AGED; ARTICLE; CANCER PROGNOSIS; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TUMOR DIFFERENTIATION; VERY ELDERLY;

CELL FREE BIRC5 MRNA; COLORECTAL CANCER; DIAGNOSIS; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARCINOEMBRYONIC ANTIGEN; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84898775021     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.23526     Document Type: Article

References (34)

1. Jemal A, Bray F, Center MM, et al.: Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
2. Zhao P, Dai M, Chen W, et al.: Cancer trends in China. Jpn J Clin Oncol 2010; 40: 281-285.
3. Fakih MG, Padmanabhan A:, CEA monitoring in colorectal cancer. What you should know. Oncology (Williston Park) 2006; 20: 579-587.
4. Tan E, Gouvas N, Nicholls RJ, et al.: Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer. Surg Oncol 2009; 18: 15-24.
5. O'Riordan MX, Bauler LD, Scott FL, et al.: Inhibitor of apoptosis proteins in eukaryotic evolution and development: A model of thematic conservation. Dev Cell 2008; 15: 497-508.
6. Augello C, Caruso L, Maggioni M, et al.: Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma. BMC Cancer 2009; 9: 125.
7. Owens TW, Foster FM, Tanianis-Hughes J, et al.: Analysis of inhibitor of apoptosis protein family expression during mammary gland development. BMC Dev Biol 2010; 10: 71.
8. Chen X, Wang T, Yang D, et al.: Expression of the IAP protein family acts cooperatively to predict prognosis in human bladder cancer patients. Oncol Lett 2013; 5: 1278-1284.
9. Ambrosini G, Adida C, Altieri DC:, A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3: 917-921.
10. Yamagishi Y, Honda T, Tanno Y, et al.: Two histone marks establish the inner centromere and chromosome bi-orientation. Science 2010; 330: 239-243.
11. Mehrotra S, Languino LR, Raskett CM, et al.: IAP regulation of metastasis. Cancer Cell 2010; 17: 53-64.
12. Caldas H, Fangusaro JR, Boue DR, et al.: Dissecting the role of endothelial SURVIVIN DeltaEx3 in angiogenesis. Blood 2007; 109: 1479-1489.
13. Ye Q, Cai W, Zheng Y, et al.: ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer. Oncogene 2013; DOI: 10.1038/onc.2013.122 [in press].
14. Yamanaka K, Nakata M, Kaneko N, et al.: YM155, a selective survivin suppressant, inhibits tumor spread and prolongs survival in a spontaneous metastatic model of human triple negative breast cancer. Int J Oncol 2011; 39: 569-575.
15. Okamoto K, Okamoto I, Okamoto W, et al.: Role of survivin in EGFR inhibitor-induced apoptosis in non-small cell lung cancers positive for EGFR mutations. Cancer Res 2010; 70: 10402-10410.
16. Gradilone A, Petracca A, Nicolazzo C, et al.: Prognostic significance of survivin-expressing circulating tumour cells in T1G3 bladder cancer. BJU Int 2010; 106: 710-715.
17. Li J, Chen P, Li XQ, et al.: Elevated levels of survivin and livin mRNA in bronchial aspirates as markers to support the diagnosis of lung cancer. Int J Cancer 2013; 132: 1098-1104.
18. Jha K, Shukla M, Pandey M:, Survivin expression and targeting in breast cancer. Surg Oncol 2012; 21: 125-131.
19. Krieg A, Werner TA, Verde PE, et al.: Prognostic and clinicopathological significance of survivin in colorectal cancer: A meta-analysis. PLoS ONE 2013; 8: e65338.
20. Zhang X, Wang C, Wang L, et al.: Detection of circulating Bmi-1 mRNA in plasma and its potential diagnostic and prognostic value for uterine cervical cancer. Int J Cancer 2012; 131: 165-172.
21. Garcia JM, Pena C, Garcia V, et al.: Prognostic value of LISCH7 mRNA in plasma and tumor of colon cancer patients. Clin Cancer Res 2007; 13: 6351-6358.
22. Pucciarelli S, Rampazzo E, Briarava M, et al.: Telomere-specific reverse transcriptase (hTERT) and cell-free RNA in plasma as predictors of pathologic tumor response in rectal cancer patients receiving neoadjuvant chemoradiotherapy. Ann Surg Oncol 2012; 19: 3089-3096.
23. Stein U, Burock S, Herrmann P, et al.: Circulating MACC1 transcripts in colorectal cancer patient plasma predict metastasis and prognosis. PLoS ONE 2012; 7: e49249.
24. Khan S, Jutzy JM, Aspe JR, et al.: Survivin is released from cancer cells via exosomes. Apoptosis 2011; 16: 1-12.
25. Schwarzenbach H, Hoon DS, Pantel K:, Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 2011; 11: 426-437.
26. Wang T, Qian X, Wang Z, et al.: Detection of cell-free BIRC5 mRNA in effusions and its potential diagnostic value for differentiating malignant and benign effusions. Int J Cancer 2009; 125: 1921-1925.
27. Khan S, Jutzy JM, Valenzuela MM, et al.: Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer. PLoS ONE 2012; 7: e46737.
28. Sarela AI, Macadam RC, Farmery SM, et al.: Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma. Gut 2000; 46: 645-650.
29. Sprenger T, Rodel F, Beissbarth T, et al.: Failure of downregulation of survivin following neoadjuvant radiochemotherapy in rectal cancer is associated with distant metastases and shortened survival. Clin Cancer Res 2011; 17: 1623-1631.
30. Kalliakmanis JG, Kouvidou C, Latoufis C, et al.: Survivin expression in colorectal carcinomas: Correlations with clinicopathological parameters and survival. Dig Dis Sci 2010; 55: 2958-2964.
31. Chu XY, Chen LB, Wang JH, et al.: Overexpression of survivin is correlated with increased invasion and metastasis of colorectal cancer. J Surg Oncol 2012; 105: 520-528.
32. Ponnelle T, Chapusot C, Martin L, et al.: Cellular localisation of survivin: Impact on the prognosis in colorectal cancer. J Cancer Res Clin Oncol 2005; 131: 504-510.
33. Hernandez JM, Farma JM, Coppola D, et al.: Expression of the antiapoptotic protein survivin in colon cancer. Clin Colorectal Cancer 2011; 10: 188-193.
34. Bao R, Connolly DC, Murphy M, et al.: Activation of cancer-specific gene expression by the survivin promoter. J Natl Cancer Inst 2002; 94: 522-528.